Verenium +57% premarket after BASF buyout offer


Industrial biotech company Verenium (VRNM) +57.7% premarket after agreeing to be acquired by BASF (BASFY.PK) for ~$51.2M, or $4/share, a 59% premium to Thursday's closing price.

VRNM focuses on developing and selling high-performance enzymes used in food and fuel markets.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs